Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Newron announces approval for pivotal Phase III study of Evenamide | 4 | 105 | May 12, 2025 | |
| Newron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia | 5 | 677 | June 9, 2022 | |
| Evenamide could be a potential breakthrough treatment in the management of treatment-resistant schizophrenia (TRS) patients | 2 | 422 | February 17, 2023 | |
| Newron Completes Enrollment of Schizophrenia Patients in Potentially Pivotal | 0 | 193 | December 29, 2023 | |
| Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA | 3 | 356 | January 9, 2020 |